ARS Wealth Advisors Group’s GSK GSK Stock Holding History

ARS Wealth Advisors Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.69M	Buy	127,638 +122	+0.1%	+$6.45K	0.52%	42
2026 Q1	$7.04M	Buy	+127,516	New	+$6.91M	0.59%	40
2022 Q4	–	Sell	-8,194	Closed	-$241K	–	143
2022 Q3	$241K	Sell	8,194 -121,942	-94%	-$4.62M	0.04%	132
2022 Q2	$7.08M	Buy	+130,136	New	+$7.18M	0.97%	38

Other funds holding GSK

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

ARS Wealth Advisors Group's GSK Position: Q2 2026 in Review

ARS Wealth Advisors Group increased its GSK (GSK) stake by 0.1% in Q2 2026, buying an estimated $6.45K and bringing the position to 127,638 shares worth $6.69M. The position accounts for 0.52% of the portfolio, ranked #42.

ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 4 quarters since. The position peaked at $7.08M in Q2 2022. 370 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

ARS Wealth Advisors Group held 127,638 shares of GSK worth $6.69M as of Q2 2026.
ARS Wealth Advisors Group bought 122 GSK shares in Q2 2026, an estimated $6.45K.
GSK made up 0.52% of ARS Wealth Advisors Group's portfolio in Q2 2026, its #42 holding.
ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 4 quarters since.
ARS Wealth Advisors Group's GSK position peaked at $7.08M in Q2 2022.
370 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q2 2026, filed 16 Jul 2026.